Content area
Full text
Canada’s Altasciences has penned a new deal that sees it snap up the preclinical testing business of SNBL USA.
The buyout will add “comprehensive preclinical safety testing services” to Altasciences’ current clinical and bioanalytical offerings.
This sees the midsized CRO add to its services, now offering everything from lead candidate selection to proof of concept.